215 related articles for article (PubMed ID: 22595371)
1. The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features.
Kara E; Ling H; Pittman AM; Shaw K; de Silva R; Simone R; Holton JL; Warren JD; Rohrer JD; Xiromerisiou G; Lees A; Hardy J; Houlden H; Revesz T
Neurobiol Aging; 2012 Sep; 33(9):2231.e7-2231.e14. PubMed ID: 22595371
[TBL] [Abstract][Full Text] [Related]
2. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
[TBL] [Abstract][Full Text] [Related]
3. Unclassifiable tauopathy associated with an A152T variation in MAPT exon 7.
Kovacs GG; Wöhrer A; Ströbel T; Botond G; Attems J; Budka H
Clin Neuropathol; 2011; 30(1):3-10. PubMed ID: 21176711
[TBL] [Abstract][Full Text] [Related]
4. The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristics.
Moreno F; Indakoetxea B; Barandiaran M; Caballero MC; Gorostidi A; Calafell F; Gabilondo A; Tainta M; Zulaica M; Martí Massó JF; López de Munain A; Sánchez-Juan P; Lee SE
PLoS One; 2017; 12(6):e0178093. PubMed ID: 28594853
[TBL] [Abstract][Full Text] [Related]
5. Tau/MAPT disease-associated variant A152T alters tau function and toxicity via impaired retrograde axonal transport.
Butler VJ; Salazar DA; Soriano-Castell D; Alves-Ferreira M; Dennissen FJA; Vohra M; Oses-Prieto JA; Li KH; Wang AL; Jing B; Li B; Groisman A; Gutierrez E; Mooney S; Burlingame AL; Ashrafi K; Mandelkow EM; Encalada SE; Kao AW
Hum Mol Genet; 2019 May; 28(9):1498-1514. PubMed ID: 30590647
[TBL] [Abstract][Full Text] [Related]
6. Early-onset familial lewy body dementia with extensive tauopathy: a clinical, genetic, and neuropathological study.
Clarimón J; Molina-Porcel L; Gómez-Isla T; Blesa R; Guardia-Laguarta C; González-Neira A; Estorch M; Ma Grau J; Barraquer L; Roig C; Ferrer I; Lleó A
J Neuropathol Exp Neurol; 2009 Jan; 68(1):73-82. PubMed ID: 19104444
[TBL] [Abstract][Full Text] [Related]
7. Enhanced phosphorylation of T153 in soluble tau is a defining biochemical feature of the A152T tau risk variant.
Carlomagno Y; Chung DC; Yue M; Kurti A; Avendano NM; Castanedes-Casey M; Hinkle KM; Jansen-West K; Daughrity LM; Tong J; Phillips V; Rademakers R; DeTure M; Fryer JD; Dickson DW; Petrucelli L; Cook C
Acta Neuropathol Commun; 2019 Jan; 7(1):10. PubMed ID: 30674342
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings.
Lees AJ
Mov Disord; 2003 Sep; 18 Suppl 6():S28-33. PubMed ID: 14502653
[TBL] [Abstract][Full Text] [Related]
9. Pallidonigroluysian atrophy associated with p.A152T variant in MAPT.
Graff-Radford J; Whitwell JL; Dickson DW; Josephs KA
Parkinsonism Relat Disord; 2013 Sep; 19(9):838-41. PubMed ID: 23692670
[No Abstract] [Full Text] [Related]
10. A152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction.
Lopez A; Lee SE; Wojta K; Ramos EM; Klein E; Chen J; Boxer AL; Gorno-Tempini ML; Geschwind DH; Schlotawa L; Ogryzko NV; Bigio EH; Rogalski E; Weintraub S; Mesulam MM; ; Fleming A; Coppola G; Miller BL; Rubinsztein DC
Brain; 2017 Apr; 140(4):1128-1146. PubMed ID: 28334843
[TBL] [Abstract][Full Text] [Related]
11. Tau mutant A152T, a risk factor for FTD/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model.
Pir GJ; Choudhary B; Mandelkow E; Mandelkow EM
Mol Neurodegener; 2016 Apr; 11():33. PubMed ID: 27118310
[TBL] [Abstract][Full Text] [Related]
12. Tauopathies as clinicopathological entities.
Irwin DJ
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S29-33. PubMed ID: 26382841
[TBL] [Abstract][Full Text] [Related]
13. Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies.
Stanford PM; Brooks WS; Teber ET; Hallupp M; McLean C; Halliday GM; Martins RN; Kwok JB; Schofield PR
J Neurol; 2004 Sep; 251(9):1098-104. PubMed ID: 15372253
[TBL] [Abstract][Full Text] [Related]
14. Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series.
Kim EJ; Brown JA; Deng J; Hwang JL; Spina S; Miller ZA; DeMay MG; Valcour V; Karydas A; Ramos EM; Coppola G; Miller BL; Rosen HJ; Seeley WW; Grinberg LT
J Neurol; 2018 Dec; 265(12):2960-2971. PubMed ID: 30324308
[TBL] [Abstract][Full Text] [Related]
15. Invited review: Neuropathology of tauopathies: principles and practice.
Kovacs GG
Neuropathol Appl Neurobiol; 2015 Feb; 41(1):3-23. PubMed ID: 25495175
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.
Coppola G; Chinnathambi S; Lee JJ; Dombroski BA; Baker MC; Soto-Ortolaza AI; Lee SE; Klein E; Huang AY; Sears R; Lane JR; Karydas AM; Kenet RO; Biernat J; Wang LS; Cotman CW; Decarli CS; Levey AI; Ringman JM; Mendez MF; Chui HC; Le Ber I; Brice A; Lupton MK; Preza E; Lovestone S; Powell J; Graff-Radford N; Petersen RC; Boeve BF; Lippa CF; Bigio EH; Mackenzie I; Finger E; Kertesz A; Caselli RJ; Gearing M; Juncos JL; Ghetti B; Spina S; Bordelon YM; Tourtellotte WW; Frosch MP; Vonsattel JP; Zarow C; Beach TG; Albin RL; Lieberman AP; Lee VM; Trojanowski JQ; Van Deerlin VM; Bird TD; Galasko DR; Masliah E; White CL; Troncoso JC; Hannequin D; Boxer AL; Geschwind MD; Kumar S; Mandelkow EM; Wszolek ZK; Uitti RJ; Dickson DW; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; ; Ross OA; Rademakers R; Schellenberg GD; Miller BL; Mandelkow E; Geschwind DH
Hum Mol Genet; 2012 Aug; 21(15):3500-12. PubMed ID: 22556362
[TBL] [Abstract][Full Text] [Related]
17. A heterozygous splicing variant IVS9-7A > T in intron 9 of the MAPT gene in a patient with right-temporal variant frontotemporal dementia with atypical 4 repeat tauopathy.
Mori K; Shigenobu K; Beck G; Uozumi R; Satake Y; Suzuki M; Kondo S; Gotoh S; Yonenobu Y; Kawai M; Suzuki Y; Saito Y; Morii E; Hasegawa M; Mochizuki H; Murayama S; Ikeda M
Acta Neuropathol Commun; 2023 Aug; 11(1):130. PubMed ID: 37563653
[TBL] [Abstract][Full Text] [Related]
18. Concurrent tau pathologies in frontotemporal lobar degeneration with TDP-43 pathology.
Koga S; Zhou X; Murakami A; Fernandez De Castro C; Baker MC; Rademakers R; Dickson DW
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12778. PubMed ID: 34823271
[TBL] [Abstract][Full Text] [Related]
19. A novel tau mutation, p.K317N, causes globular glial tauopathy.
Tacik P; DeTure M; Lin WL; Sanchez Contreras M; Wojtas A; Hinkle KM; Fujioka S; Baker MC; Walton RL; Carlomagno Y; Brown PH; Strongosky AJ; Kouri N; Murray ME; Petrucelli L; Josephs KA; Rademakers R; Ross OA; Wszolek ZK; Dickson DW
Acta Neuropathol; 2015 Aug; 130(2):199-214. PubMed ID: 25900293
[TBL] [Abstract][Full Text] [Related]
20. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
